McDermott N - Search Results

1

Isogenic radiation resistant cell lines: development and validation strategies.

McDermott N, Meunier A, Lynch TH, Hollywood D, Marignol L. McDermott N, et al. Int J Radiat Biol. 2014 Feb;90(2):115-26. doi: 10.3109/09553002.2014.873557. Int J Radiat Biol. 2014. PMID: 24350914 Review.

2

NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer.

Belle VA, McDermott N, Meunier A, Marignol L. Belle VA, et al. Among authors: mcdermott n. Nat Rev Urol. 2014 Sep;11(9):499-507. doi: 10.1038/nrurol.2014.195. Epub 2014 Aug 19. Nat Rev Urol. 2014. PMID: 25134838 Free PMC article. Review.

3

Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells.

Lawlor H, Meunier A, McDermott N, Lynch TH, Marignol L. Lawlor H, et al. Among authors: mcdermott n. Tumour Biol. 2015 Aug;36(8):6019-28. doi: 10.1007/s13277-015-3278-5. Epub 2015 Mar 7. Tumour Biol. 2015. PMID: 25750034

4

Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells.

Meunier A, Belle VA, McDermott N, Rivera-Figueroa K, Perry A, Lynch T, Redalen KR, Marignol L. Meunier A, et al. Among authors: mcdermott n. Heliyon. 2016 May 5;2(5):e00104. doi: 10.1016/j.heliyon.2016.e00104. eCollection 2016 May. Heliyon. 2016. PMID: 27441277 Free PMC article.

5

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.

McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S, Lynam-Lennon N, Barsoom SH, Bowman KJ, Marples B, Jones GD, Marignol L. McDermott N, et al. Sci Rep. 2016 Oct 5;6:34796. doi: 10.1038/srep34796. Sci Rep. 2016. PMID: 27703211 Free PMC article.

6

The Notch-3 receptor: A molecular switch to tumorigenesis?

Inder S, O'Rourke S, McDermott N, Manecksha R, Finn S, Lynch T, Marignol L. Inder S, et al. Among authors: mcdermott n. Cancer Treat Rev. 2017 Nov;60:69-76. doi: 10.1016/j.ctrv.2017.08.011. Epub 2017 Sep 1. Cancer Treat Rev. 2017. PMID: 28889086 Review.

7

Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.

McDermott N, Meunier A, Wong S, Buchete V, Marignol L. McDermott N, et al. Clin Transl Radiat Oncol. 2017 Feb 17;2:63-68. doi: 10.1016/j.ctro.2017.01.005. eCollection 2017 Feb. Clin Transl Radiat Oncol. 2017. PMID: 29658003 Free PMC article.

8

Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance.

Inder S, Bates M, Ni Labhrai N, McDermott N, Schneider J, Erdmann G, Jamerson T, Belle VA, Prina-Mello A, Thirion P, Manecksha PR, Cormican D, Finn S, Lynch T, Marignol L. Inder S, et al. Among authors: mcdermott n. Sci Rep. 2019 Nov 22;9(1):17325. doi: 10.1038/s41598-019-53799-7. Sci Rep. 2019. PMID: 31758038 Free PMC article.

9

YB-1: The key to personalised prostate cancer management?

Bates M, Boland A, McDermott N, Marignol L. Bates M, et al. Among authors: mcdermott n. Cancer Lett. 2020 Oct 10;490:66-75. doi: 10.1016/j.canlet.2020.07.006. Epub 2020 Jul 16. Cancer Lett. 2020. PMID: 32681926 Free article. Review.

10

Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.

Ma J, Shah R, Bell AC, McDermott N, Pei X, Selenica P, Haseltine J, Delsite R, Khan AJ, Lok BH, Ellis MJ, Aft RF, Setton J, Reis-Filho JS, Riaz N, Powell SN. Ma J, et al. Among authors: mcdermott n. Int J Radiat Oncol Biol Phys. 2024 Jul 10:S0360-3016(24)02946-8. doi: 10.1016/j.ijrobp.2024.06.037. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38997095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters